76	Atazanavir_cobicistat
Atazanavir/cobicistat &&&&& Introduction &&&&& &&&&& &&&&& '''Atazanavir/cobicistat''' (trade name '''Evotaz''') is an antiretroviral medication used to treat and prevent HIV/AIDS. It is a fixed dose combination drug containing 300 mg of atazanavir and 150 mg of cobicistat. Atazanavir is an HIV protease inhibitor and cobicistat blocks the body's metabolism of atazanavir by the enzyme CYP3A prolonging its effectiveness. &&&&& &&&&& It was approved by the Food and Drug Administration for use in United States in 2015. &&&&& &&&&& References &&&&& &&&&& &&&&& &&&&& &&&&& &&&&& &&&&& &&&&& 